STRATEGIC PLAN Q2 2019 - MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF

 
CONTINUE READING
STRATEGIC PLAN Q2 2019 - MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF
STRATEGIC PLAN    Q2 2019

MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF                    PRIVILEGED & CONFIDENTIAL
STRATEGIC PLAN Q2 2019 - MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF
Confidentiality Statement and Legal Disclaimer
  This Business Plan is confidential. Unauthorized reproduction or distribution of it or any of its contents in any form or under any circumstances without prior written consent is prohib-

  ited. The Recipient is responsible for returning all copies of the Plan immediately upon request of the Company. The information contained herein is: (i) provided by the principal found-

  ers of the business and (ii) publicly available from directories, publications, and websites, as mentioned in the body and the footnotes where possible or appropriate. In some cases,

  non-publicly available information was used, including independent research, studies or paid services from individuals and organizations. While the information set forth herein is

  deemed by the Company to be accurate, the Company shall not be held liable for the accuracy of or any omissions from this Business Plan or for any other written or oral communica-

  tion transmitted to the Recipient and any other party in the course of its evaluation of transactions involving the Company.

  The information contained in the plan will require careful scrutiny, verification and due diligence efforts from the Recipients of the plan. Any person or entity seeking to make an

  investment in the business should not rely on the information set forth in the plan as complete. In addition, the analyses contained herein do not claim to be appraisals of the assets or

  the valuation of any entity. The business makes no guarantees regarding any benefits received from an investment, nor the legal, tax or accounting effects of any transaction; and this

  Plan does not constitute an offer to sell, or a solicitation of an offer to buy securities. In furnishing the Business Plan, the Company undertakes no obligation to provide Recipients of

  the Business Plan with access to any additional information or to update this Business Plan or to correct any inaccuracies that may be contained herein. There exists substantial

  information with respect to the business and its future prospects, and there are a substantial number of risks associated with an investment in the business, which are not set forth in

  the plan.

  Furthermore, the potential fulfillment of “forward looking statements” contained in the plan are subject to change due to unexpected events, market shifts, or circumstances that

  cannot be known at this time. Forward looking statements are based on expectations, estimates and projections at the time the statements were made that involve a number of eco-

  nomic, business, and numerous risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in

  the plan may be identified through the use of words such as, but not exclusively to: “expects,” “will,” “anticipates,” “estimates,” “believes,” or statements indicating certain actions

  “may,” “could,” or “might” occur. Such estimates and projections are subject to significant uncertainties beyond the control of the Company. Although such projections are believed to

  be realistic, no representations are made as to their ultimate attainability.

MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF                                                                                                                        PRIVILEGED & CONFIDENTIAL
STRATEGIC PLAN Q2 2019 - MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF
MYM Nutraceuticals is focused on constructing
                         high quality cultivation facilities around the�world
                         while building, acquiring, and growing businesses
                         and brands to become a world class�global cannabis
                         and hemp company.

MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF                                PRIVILEGED & CONFIDENTIAL
STRATEGIC PLAN Q2 2019 - MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF
Cultivation                              Extraction                         Distribution                          Unique Brands
MYM is positioning itself to             MYM ‘s cultivation projects        By creating strategic geographic      MYM is in the process of building
become a global leader in                include extraction capabilities    partnerships around the world,        a number of cannabis brands for
cannabis, hemp, and seed                 and expertise. The ability to      MYM is in a prime position to take    use in a wide variety of global
cultivation. Through a variety of        extract the biomass that is        advantage of economical               markets. Market research is being
global partnerships in agricultural      cultivated on-site will provide    distribution channels. Having         assessed across the globe to
friendly zones, MYM will have            MYM with an economic               interests in every corner of the      determine what each country’s
cultivation centres around the           advantage, lowering the costs of   globe will make the distribution of   consumers will demand in a
globe. Our ability to cultivate          producing extracts and in turn     cannabis products a viable option     cannabis brand.
indoor, outdoor and greenhouse           providing substantially higher     for every region.
cannabis and hemp will be                profit-margins to our
transferrable to other projects          shareholders.
around the world.

  MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF                                                                          PRIVILEGED & CONFIDENTIAL
STRATEGIC PLAN Q2 2019 - MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF
Global Operations

                      WEEDON, CANADA
                      Annual Production
                       at Full Capacity =
  NEVADA, USA            160,000 kgs                                          CANNABIS
Annual Production                                        LAVAL, CANADA
 at Full Capacity =                                     Annual Production
                                                                              HEMP
    54,000 kgs                                           at Full Capacity =
                                                             2,580 kgs        MEDICAL
                       NAVAJO NATION, USA
                         Annual Production                                    EXTRACTION
       MEXICO             at Full Capacity =
                          13,700,000 kgs
   Importation and
    Distribution of
   Hemp Products

                                       MEDELLIN, COLOMBIA
                                                                                                        AUSTRALIA
                                            Annual Production
                                                                                                     Annual Production
                                             at Full Capacity =
                                                                                                      at Full Capacity =
                                               585,000 kgs
                                                                                                              TBD

MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF                                                PRIVILEGED & CONFIDENTIAL
STRATEGIC PLAN Q2 2019 - MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF
NAVAJO NATION, USA
                                               MYM has partnered to grow 3,000 acres of hemp
                                               with the Navajo Nation in New Mexico. The recent
                                               passing of the Farm Bill saw CBD-rich hemp
                                               removed from the classified drug list, opening the
                                               door for farmers to legally grow CBD-rich hemp
                                               biomass. This partnership will create hundreds of
                                               jobs for the Navajo people and millions of kgs of
                                               CBD-rich hemp biomass.

                                                    YEAR ONE TARGETING 100 ACRES
                                                    OF CBD-RICH HEMP FARMING

                                                    YEAR FIVE TARGET 3,000 ACRES
                                                    OF CBD-RICH HEMP FARMING

                                                    HUNDREDS JOBS CREATED IN
                                                    HISTORICALLY A DEPRESSED AREA

Large-scale hemp cultivation project on   3000 acres  of USDA compliant
                                                  TOTAL ANNUAL PRODUCTION
resource rich Navajo land                 cultivation land
                                                  AT FULL   located
                                                          CAPACITY    on the Navajo
                                                                   = 13,700,000 KGS

                                          Nation
STRATEGIC PLAN Q2 2019 - MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF
NEVADA, USA
Partnership with Elite Ventures to grow 125 acres of
CBD-rich hemp in Nevada. Elite will plant, grow, and
harvest the hemp. Based on previous crops grown on
the property, the estimated production is 54,000 kgs
per harvest with potential revenue of $26 million of
which MYM is entitled to 50%.

     ESTIMATED CBD LEVELS
     BETWEEN 10%-19%

     POTENTIAL ANNUAL REVENUE
     OF OVER $17,500,000

     POTENTIAL TO INCREASE ACREAGE
     FOR 2020 GROWING SEASON

     TOTAL ANNUAL PRODUCTION AT                        CBD-rich hemp production
     FULL CAPACITY = 27,000 KGS
                                                       agreement with immediate revenue
                                                       generating potential
STRATEGIC PLAN Q2 2019 - MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF
WEEDON, CANADA
                                          The 1.5 million sf greenhouse project has been
                                          approved by the City of Weedon. A license
                                          application has been submitted to Health Canada.
                                          Once approved, the Weedon project has the
                                          potential to be one of the largest cannabis
                                          production facilities in Canada.

                                               SUBMIT EVIDENCE PACKAGE
                                               FOR HEALTH CANADA BY Q4 2019

                                               MYM HAS PURCHASED 329 ACRES
                                               TO BUILD THE PROJECT

                                               INITIAL BUILD OUT OF 30,000 SQ FT
                                               GREENHOUSE IS UNDERWAY

Potentially one of the largest       3000 acres  of USDA compliant
                                             TOTAL ANNUAL PRODUCTION AT
greenhouse cultivation projects in   cultivation
                                             FULLland located
                                                  CAPACITY       on the
                                                           = 160,000 KGS Navajo

Canada                               Nation
STRATEGIC PLAN Q2 2019 - MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF
LAVAL, CANADA
Cutting edge, highly optimized, indoor facility with a
planned 37,000 sf that will harvest every 21 days.
Facility includes mothering and cloning area allowing
for exceptional genetic development and archiving.
At 10,000 sf, Phase 1 is complete and awaiting
licensing from Health Canada. The Cannabis Tracking
and Licensing System has been completed and filed.
The facility plans to focus on high quality specialty
“craft” cannabis varieties.

     CULTIVATION LICENSE FOR PHASE
     ONE IS EXPECTED IN Q2 2019

     CROPS FOR VALIDATION WITH
     HEALTH CANADA IN Q3 2019

     SALE OF SEEDS AS ADDITIONAL
     REVENUE STREAM
                                                         Small batch, super premium, indoor
     TOTAL ANNUAL PRODUCTION AT                          cannabis production facility
     FULL CAPACITY = 2,580 KGS
STRATEGIC PLAN Q2 2019 - MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF
AUSTRALIA
                                   MYM is exploring a number of projects in Australia
                                   with the goal of becoming one of the largest cannabis
                                   producers in the Southern Hemisphere.

                                        CURRENTLY NEGOTIATING DEALS IN
                                        EXCESS OF 1000 ACRES

                                        IN NEGOTIATIONS WITH MULTI
                                        GENERATIONAL FARMERS IN THE REGION

                                        ESTIMATED FIRST CULTIVATION
                                        IN EARLY 2020

                                        TOTAL PRODUCTION = TBD
Launching point for Asia Pacific
operations
MEDELLIN, COLOMBIA
MYM has acquired 80% of Colombia Organica , a
Colombian company that holds 3 licenses: production
of THC cannabis derivatives, cultivation of
psychoactive cannabis, and cultivation of
non-psychoactive cannabis, including exportation.
Colombia Organica has selected for production high
quality plants which are suited to the unique high
altitude, equatorial regions of Colombia.

     LICENSES WILL BE EXTENDED TO OTHER
     PROPERTIES WITHIN THE COUNTRY

     PROJECT UNDERWAY TO BUILD A
     PRODUCTION FACILITY NEAR MEDELLIN

     APPLICATION SUBMITTED TO REGISTER
     102 CANNABIS STRAINS

     TOTAL ANNUAL PRODUCTION AT
                                                      Launching point to South American
     FULL CAPACITY = 585,000 KGS                      operations with initial 34 acre outdoor
                                                      and greenhouse grow
MEXICO
                                   MYM has incorporated “MYM Nutraceuticals Mexico
                                   S.A. de C.V.” and built a well-connected team to
                                   ensure the company’s place as a first-mover in the
                                   Mexican cannabis industry. The Mexican government
                                   is currently considering significant cannabis reform
                                   at the national level. MYM aims to be at the forefront
                                   of this movement by positioning the company to be a
                                   key player in the importation and distribution of
                                   CBD-rich hemp products. The expected changes in
                                   cannabis legislation will make products like
                                   hemp-derived CBD available on the shelves of
                                   general retailers across the nation.

                                        POPULATION OF OVER 130 MILLION PEOPLE
                                        WITH ACCESS TO CBD-RICH HEMP RETAILERS

                                        MOTIVATED GOVERNMENT ON THE
                                        VERGE OF CANNABIS REFORM

                                        WELL CONNECTED TEAM WITH ACCESS TO
                                        VARIOUS LEVELS OF GOVERNMENT
First-movers for importation and
distribution of CBD-rich hemp           FIRST-MOVER ADVANTAGE FOR THE
                                        IMPORTATION AND DISTRIBUTION
products in Central America             OF CBD PRODUCTS
Production Totals

                                  Yield          Footprint

                        14.5 M                  3,205
                    Kilograms of Cannabis     Acres of Production
                       & Hemp Per Year

MYM NUTRACEUTICALS INC. CSE: MYM OTC: MYMMF                    PRIVILEGED & CONFIDENTIAL
Senior Management

                                                                                   Howard Steinberg
                                                                                  Executive Vice Chairman of                                             Erick Factor
                                                                                      the Board and CEO
                                                                                                                                                 Executive Chairman, Founder

                                                                                  Mr. Steinberg has more than 20 years                           Mr. Erick Factor has been appointed to
                                                                                    investment experience as a senior                            the Company’s Board of Directors and
                                                                                 executive, working within some of the                           will also serve as Executive Chairman.
                                                                               largest financial institutions in the world.                        Mr. Factor is a well-known expert in
                                                                                   He has sat on over a dozen Boards                               the cannabis industry and has 20
                                                                                 including his current role as Executive                           years of experience in cultivating
                                                                                   Chairman of Parallax Developments                                      medical marijuana and
                                                                                      Corp and as a board member of                                           manufacturing.
                                                                                            Trichome Financial.

Elizabeth Liu, QC                            Robin Linden                               Mark Forster                            Charith Adkar                                             Paul Cheetham
Executive Vice-President                 Executive Vice President                    Chief Financial Officer                     Chief Science Officer                                      Chief Operating Officer
 and Chief Legal Officer                 and Chief Marketing Officer
                                                                                     Mark Forster has 30 years of            Charith Adkar completed his PhD in                      A Harvard Business School alumnus,
  Ms. Liu will provide the company        Robin Linden contributes over 20            experience in financial and             Plant Biology and Crop Production                           Mr. Cheetham has extensive
with a broad range of strategic and     years of leadership and management       management accounting in banking,           from the University of Milano, Italy                    experience leading teams across the
  risk management advice. Ms. Liu         experience, including roles in the                                                 with the specialization in Molecular
                                                                                manufacturing, oil and gas, and mining                                                                      finance, marketing and
 has acted for both early stage and
                                          adult beverage, luxury retail, and     companies. His prior CFO experience          Plant Pathology. He has done his                        communications, and technology
   established companies and has
served as the chief operating officer
                                               luxury hotel industries.           includes Oracle Energy Corps and            postdoctoral studies at Hirosaki                                    industries.
   for a number of them including                                                       Teletouch Services Inc.              University, Japan and Université de
some in the natural health products                                                                                                 Sherbrooke, Canada.
   industry. Ms. Liu was appointed
       Queen’s Counsel in 2016.
Facilities & Territories

                                             SOUTH
 CANADA                    USA              AMERICA              ASIA PACIFIC
 Fabian Garcia        James Andrews
Zach Tietolman                              Daniel Alonso        Fabian Szatmary
                       Territory Manager   Gabriel Ramirez         Territory Manager
 Territory Managers
                                            Territory Managers
Capital Structure

             CSE:MYM
            OTC:MYMMF
Shares Issued    Total Options           Outstanding
& Outstanding     Outstanding             Warrants
125,700,000       10,100,000             14,100,000

       Outstanding Warrants & Options
                24,200,000

          Total Shares Fully Diluted
                149,900,000

                As of February 8, 2019
Vancouver                             Toronto            USA
#250 1095 W Pender St             #108 250 Carlaw Ave   11 S Swinton Ave
    Vancouver BC                      Toronto ON        Delray Beach FL
       V6E 2M6                          M4M 3L1               33444
   1-604-559-7513
    info@mym.ca

             PRIVILEGED & CONFIDENTIAL
You can also read